MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,184,815 | +43.9% | 1,733,757 | +19.1% | 0.01% | +50.0% |
| Q2 2023 | $37,652,362 | +12.5% | 1,455,445 | +4.5% | 0.01% | +14.3% |
| Q1 2023 | $33,458,539 | +19.4% | 1,392,945 | -3.1% | 0.01% | +16.7% |
| Q4 2022 | $28,024,601 | +41.5% | 1,437,159 | +52.4% | 0.01% | +50.0% |
| Q3 2022 | $19,808,000 | +129.0% | 942,777 | +112.1% | 0.00% | +100.0% |
| Q2 2022 | $8,649,000 | +6.0% | 444,447 | +19.9% | 0.00% | 0.0% |
| Q1 2022 | $8,163,000 | +181.1% | 370,728 | +103.7% | 0.00% | – |
| Q4 2021 | $2,904,000 | -0.5% | 182,026 | +24.3% | 0.00% | – |
| Q3 2021 | $2,919,000 | +985.1% | 146,478 | +848.9% | 0.00% | – |
| Q4 2020 | $269,000 | -48.1% | 15,437 | -42.6% | 0.00% | – |
| Q3 2020 | $518,000 | +102.3% | 26,879 | +104.6% | 0.00% | – |
| Q2 2020 | $256,000 | – | 13,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |